Suppr超能文献

在全国性的肠道筛查计划中采用双层反射式 gFOBT/FIT 策略的经验。

Experience with a two-tier reflex gFOBT/FIT strategy in a national bowel screening programme.

机构信息

Centre for Research into Cancer Prevention & Screening, University of Dundee Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland.

出版信息

J Med Screen. 2012 Mar;19(1):8-13. doi: 10.1258/jms.2011.011098. Epub 2011 Dec 7.

Abstract

OBJECTIVES

To evaluate a two-tier reflex guaiac-based faecal occult blood test (gFOBT)/faecal immunochemical test (FIT) algorithm in screening for colorectal cancer.

SETTING

Fourth screening round in NHS Tayside (Scotland).

METHODS

gFOBT were sent to 50-74-year-olds. Participants with five or six windows positive were offered colonoscopy. Participants with one to four windows positive were sent a FIT and, if positive, were offered colonoscopy. Participants providing an untestable gFOBT were sent a FIT and, if positive, were offered colonoscopy. Outcomes following positive results, cancer stages and key performance indicators were assessed.

RESULTS

Of 131,885 invited, 73,315 (55.6%) responded. There were 66,957 (91.3%) negative, 241 (0.3%) strong positive, 5230 (7.1%) weak positive and 887 (1.2%) untestable results. The 241 participants who had five or six windows positive had more cancers than those positive by other routes: only 3 of the 30 cancers (9.7%) were Dukes' A. Among the 983 positive results from the weak positive gFOBT then positive FIT route, there were fewer cancers and more normal colonoscopies, but more adenomas than in the group with a strong positive gFOBT. In those with an untestable gFOBT, 77 had a positive FIT result, with fewer true and more false positive results than in the other groups. Fewer males had cancer and stages were earlier than in females, but more had adenoma. The detection rate for cancer was 0.18% and the PPV for cancer and all adenomas was 41.3%.

CONCLUSIONS

The algorithm and FIT following a weak positive gFOBT have advantages. FIT following an untestable gFOBT warrants review.

摘要

目的

评估一种两阶段基于愈创木脂的粪便潜血检测(gFOBT)/粪便免疫化学检测(FIT)算法在结直肠癌筛查中的应用。

背景

苏格兰 NHS Tayside 的第四次筛查轮次。

方法

向 50-74 岁人群发送 gFOBT。如果有五个或六个窗口呈阳性,参与者将接受结肠镜检查。如果有一到四个窗口呈阳性,参与者将被发送 FIT,如果呈阳性,将提供结肠镜检查。如果无法进行 gFOBT 检测,参与者将被发送 FIT,如果呈阳性,将提供结肠镜检查。评估阳性结果、癌症分期和关键性能指标。

结果

在邀请的 131885 人中,有 73315 人(55.6%)做出回应。结果为阴性的有 66957 人(91.3%),强阳性的有 241 人(0.3%),弱阳性的有 5230 人(7.1%),无法检测的有 887 人(1.2%)。有五个或六个窗口呈阳性的 241 名参与者比其他途径呈阳性的参与者有更多的癌症:30 例癌症中只有 3 例(9.7%)为 Dukes'A 期。在弱阳性 gFOBT 然后阳性 FIT 途径中,有 983 例阳性结果,癌症和正常结肠镜检查的数量较少,但腺瘤的数量比强阳性 gFOBT 组多。在无法进行 gFOBT 检测的人群中,有 77 人 FIT 检测结果呈阳性,真阳性和假阳性结果均少于其他组。男性癌症的发病率较低,分期较早,但腺瘤的发病率较高。癌症的检出率为 0.18%,癌症和所有腺瘤的阳性预测值为 41.3%。

结论

该算法和弱阳性 gFOBT 后的 FIT 具有优势。弱阳性 gFOBT 后 FIT 结果需要进一步审查。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验